195 related articles for article (PubMed ID: 24407241)
1. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN.
Liu L; Wen Q; Gong R; Gilles L; Stankiewicz MJ; Li W; Guo M; Li L; Sun X; Li W; Crispino JD; Huang Z
Cell Death Dis; 2014 Jan; 5(1):e988. PubMed ID: 24407241
[TBL] [Abstract][Full Text] [Related]
2. PSTPIP2, a Protein Associated with Autoinflammatory Disease, Interacts with Inhibitory Enzymes SHIP1 and Csk.
Drobek A; Kralova J; Skopcova T; Kucova M; Novák P; Angelisová P; Otahal P; Alberich-Jorda M; Brdicka T
J Immunol; 2015 Oct; 195(7):3416-26. PubMed ID: 26304991
[TBL] [Abstract][Full Text] [Related]
3. GATA-2 reinforces megakaryocyte development in the absence of GATA-1.
Huang Z; Dore LC; Li Z; Orkin SH; Feng G; Lin S; Crispino JD
Mol Cell Biol; 2009 Sep; 29(18):5168-80. PubMed ID: 19620289
[TBL] [Abstract][Full Text] [Related]
4. c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation.
García P; Berlanga O; Vegiopoulos A; Vyas P; Frampton J
J Thromb Haemost; 2011 Aug; 9(8):1572-81. PubMed ID: 21668739
[TBL] [Abstract][Full Text] [Related]
5. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development.
Muntean AG; Crispino JD
Blood; 2005 Aug; 106(4):1223-31. PubMed ID: 15860665
[TBL] [Abstract][Full Text] [Related]
6. A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.
Huang H; Woo AJ; Waldon Z; Schindler Y; Moran TB; Zhu HH; Feng GS; Steen H; Cantor AB
Genes Dev; 2012 Jul; 26(14):1587-601. PubMed ID: 22759635
[TBL] [Abstract][Full Text] [Related]
7. Small Rab GTPase Rab7b promotes megakaryocytic differentiation by enhancing IL-6 production and STAT3-GATA-1 association.
He D; Chen T; Yang M; Zhu X; Wang C; Cao X; Cai Z
J Mol Med (Berl); 2011 Feb; 89(2):137-50. PubMed ID: 20953574
[TBL] [Abstract][Full Text] [Related]
8. Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.
Lannutti BJ; Drachman JG
Blood; 2004 May; 103(10):3736-43. PubMed ID: 14726379
[TBL] [Abstract][Full Text] [Related]
9. Increased megakaryocytopoiesis in Lyn-deficient mice.
Lannutti BJ; Minear J; Blake N; Drachman JG
Oncogene; 2006 Jun; 25(23):3316-24. PubMed ID: 16418722
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
Elagib KE; Racke FK; Mogass M; Khetawat R; Delehanty LL; Goldfarb AN
Blood; 2003 Jun; 101(11):4333-41. PubMed ID: 12576332
[TBL] [Abstract][Full Text] [Related]
11. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.
Huang Z; Richmond TD; Muntean AG; Barber DL; Weiss MJ; Crispino JD
J Clin Invest; 2007 Dec; 117(12):3890-9. PubMed ID: 18060035
[TBL] [Abstract][Full Text] [Related]
12. GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.
Kuhl C; Atzberger A; Iborra F; Nieswandt B; Porcher C; Vyas P
Mol Cell Biol; 2005 Oct; 25(19):8592-606. PubMed ID: 16166640
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.
Elagib KE; Mihaylov IS; Delehanty LL; Bullock GC; Ouma KD; Caronia JF; Gonias SL; Goldfarb AN
Blood; 2008 Dec; 112(13):4884-94. PubMed ID: 18780834
[TBL] [Abstract][Full Text] [Related]
14. Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling.
Malinge S; Thiollier C; Chlon TM; Doré LC; Diebold L; Bluteau O; Mabialah V; Vainchenker W; Dessen P; Winandy S; Mercher T; Crispino JD
Blood; 2013 Mar; 121(13):2440-51. PubMed ID: 23335373
[TBL] [Abstract][Full Text] [Related]
15. Identification and activation of Src family kinases in primary megakaryocytes.
Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
[TBL] [Abstract][Full Text] [Related]
16. A novel role of CKIP-1 in promoting megakaryocytic differentiation.
Fan J; Wang Y; Shen Y; Liu Q; Gao R; Qiu Y; Wang C; Zhang L
Oncotarget; 2017 May; 8(18):30138-30150. PubMed ID: 28404913
[TBL] [Abstract][Full Text] [Related]
17. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
18. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
Congleton J; MacDonald R; Yen A
Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
[TBL] [Abstract][Full Text] [Related]
19. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.
Shimizu R; Kobayashi E; Engel JD; Yamamoto M
Genes Cells; 2009 Sep; 14(9):1119-31. PubMed ID: 19682090
[TBL] [Abstract][Full Text] [Related]
20. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
Front Immunol; 2018; 9():1771. PubMed ID: 30116247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
